Ra Capital Management, L.P.

10% OwnerAdicet Bio, Inc. (ACET) · full profile →Form 4 · filed Apr 13, 2026
Net Buying
Open-Market Buys
$1.6M
Open-Market Sells
$0
Net Open-Market Flow
$1.6M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 20, 2026Buy(P)75K$7.27$543K1.2M
Feb 19, 2026Buy(P)74K$7.21$535K1.1M
Feb 18, 2026Buy(P)75K$7.04$525K1.0M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001231919-26-000337) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about ACET insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001231919-26-000337"
Ask your agent
Use Arkolith to summarize insider buying and selling at Adicet Bio, Inc.
over the last 90 days and cite the filings.